Downstaging prior to liver transplantation for hepatocellular carcinoma: advisable but at the price of an increased risk of cancer recurrence - a retrospective study.
Aged
Carcinoma, Hepatocellular
/ blood
Databases, Factual
Disease-Free Survival
Female
Humans
Internet
Liver Neoplasms
/ blood
Liver Transplantation
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Patient Selection
Retrospective Studies
Risk
Severity of Illness Index
Treatment Outcome
alpha-Fetoproteins
/ analysis
cancer
downstaging
liver clinical
outcome
Journal
Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
received:
18
06
2018
revised:
13
07
2018
accepted:
23
08
2018
pubmed:
29
8
2018
medline:
8
8
2019
entrez:
29
8
2018
Statut:
ppublish
Résumé
The use of downstaging prior to liver transplantation for hepatocellular carcinoma (HCC) still needs refinement. This study included patients with HCC listed for transplantation according to the Total Tumour Volume (TTV) ≤115 cm
Substances chimiques
alpha-Fetoproteins
0
Types de publication
Journal Article
Langues
eng
Pagination
163-172Informations de copyright
© 2018 Steunstichting ESOT.